Observational Study of Muscle and Bone Disorders
This observational study is looking for adults aged 18 and older who have both a muscle disorder and a bone disorder, especially if these conditions run in their family. Researchers want to understand the genetic causes of these combined conditions. You would participate in a quick and painless procedure called Diffuse Optical Spectroscopy. This device, which looks like a barcode scanner, shines infrared light on your skin (calf, bicep, or head) to measure things like blood, water, and fat in your tissues. This helps researchers understand how your tissues work and how changes in your body's processes might affect your long-term health. The study aims to understand muscle disease within one week of measurement.
- Study design
- This is an observational study planning to enroll 25 participants. It is not a treatment study, but rather aims to understand muscle and bone disorders.
- What's involved
- You would have a Diffuse Optical Spectroscopy measurement, which involves placing a probe on your skin for a short period. The primary endpoint, muscle disease, is measured at 1 week.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, muscle disease, is measured at 1 week.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Characterization of Familial Myopathy and Paget Disease of Bone
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Virginia Kimonis, MD · PRINCIPAL_INVESTIGATOR · Beckman Laser Institute University of California Irvine
- Bruce Tromberg, PhD · STUDY_DIRECTOR · Beckman Laser Institute University of California Irvine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- muscle disease1 week